OptimizeRx (OPRX) Saham Harga

OptimizeRx Harga

NASDAQ·DITUTUP
9,35
​
Pasar ditutup

Pendapatan tumbuh 47,5% per tahun selama 18 tahun terakhir menjadi 109,43 Juta. USD. Laba per saham tumbuh 17,4% per tahun selama 12 tahun terakhir. margin bersih OptimizeRx saat ini 4,7%, naik dari 0,6% beberapa tahun lalu. Target harga median analis adalah 11,00 USD, di atas harga saat ini sebesar 17,7%. Dari 12 analis, 11 merekomendasikan beli — konsensus keseluruhan Beli.

Harga saham OptimizeRx

Akses data ini lewat Eulerpool API

100.000 permintaan/bulan gratis · tanpa kartu

Model bisnis dan analisis saham OptimizeRx

OPTIMIZERx Corporation adalah perusahaan AS yang sedang berkembang dan menerapkan pendekatan revolusioner untuk mengatasi tantangan di sektor kesehatan. Perusahaan ini didirikan pada tahun 2006 dan berkantor pusat di Rochester, Michigan. Awalnya, OPTIMIZERx beroperasi sebagai penyedia insentif diskon untuk meningkatkan manajemen obat-obatan. Selanjutnya, perusahaan mengembangkan platform E-Prescribing yang inovatif guna memastikan pengiriman obat kepada pasien secara cepat dan aman. Model bisnisnya berfokus pada penyediaan platform dan layanan yang skalabel untuk menyederhanakan serta meningkatkan pengelolaan data pasien dan komunikasi. OPTIMIZERx menawarkan produk-produk seperti eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, dan OptimizeRx 360. Platform dan layanan tersebut dijual kepada perusahaan farmasi, dokter, pasien, dan apotek untuk membantu mengurangi biaya serta mengoptimalkan proses bisnis. Perusahaan ini terbagi ke dalam beberapa kategori utama, yaitu E-Prescribing, Dukungan Berpusat pada Pasien, Layanan Titik Perawatan (Point-of-Care), serta Manajemen Saluran dan Konten. Secara keseluruhan, OPTIMIZERx bertujuan meningkatkan layanan kesehatan melalui teknologi inovatif dan telah mencapai tonggak sejarah penting, termasuk basis pelanggan yang kuat serta fondasi keuangan yang berkelanjutan.

Pertanyaan yang sering diajukan tentang saham OptimizeRx

Some of the main competitors of OPTIMIZERx Corp in the market include Updox, Allscripts Healthcare Solutions, and NextGen Healthcare.

The business model of OPTIMIZERx Corp is focused on providing software solutions and technology platforms to the healthcare industry. The company offers a comprehensive suite of services, including electronic prescribing for healthcare providers, patient engagement and adherence tools, as well as financial assistance programs for patients to help them access and afford medication. OPTIMIZERx Corp's innovative technology enables pharmaceutical manufacturers to effectively engage with healthcare professionals and patients, improving patient outcomes and reducing healthcare costs. With its unique offerings and solutions, OPTIMIZERx Corp aims to optimize the connection between patients, healthcare providers, and pharmaceutical companies in the healthcare ecosystem.

OPTIMIZERx Corp is primarily active in the healthcare and pharmaceutical industries.

OPTIMIZERx Corp is a renowned digital health company that specializes in providing software solutions to streamline the pharmaceutical industry. Founded in 2006, OPTIMIZERx has established itself as a leader in the field, offering innovative platforms to enhance patient engagement and adherence. With a focus on improving communication between healthcare providers, pharmaceutical companies, and patients, OPTIMIZERx's solutions enable physicians to deliver cost-effective and personalized care. The company has consistently grown its presence by incorporating cutting-edge technologies and strategic partnerships, ensuring it stays at the forefront of the industry. OPTIMIZERx Corp's commitment to improving patient outcomes has made it a trusted name in the digital health sector.

OPTIMIZERx Corp, a leading provider of digital health communication solutions, has achieved several significant milestones. The company experienced impressive revenue growth, surpassing $30 million in annual revenue in 2020. In addition, OPTIMIZERx Corp expanded its client base, forging partnerships with renowned pharmaceutical manufacturers, healthcare providers, and pharmacies. The company launched innovative solutions, such as its SampleRx platform, which allows patients to access cost-saving coupons and trial offers for prescription medications. OPTIMIZERx Corp also made strategic acquisitions, augmenting its capabilities and expanding its market reach. These milestones demonstrate the company's commitment to revolutionizing patient engagement and improving prescription affordability in the healthcare industry.

OPTIMIZERx Corp is primarily present in the United States.

Optimizerx Corp represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving patient access to life-saving therapies, Optimizerx Corp aims to enhance the healthcare ecosystem through its digital platform and strategic partnerships. Committed to delivering superior solutions and services, the company leverages cutting-edge technology and data-driven insights to empower patients, healthcare providers, and pharmaceutical manufacturers. Optimizerx Corp strives to optimize the healthcare experience, driving better outcomes, cost-savings, and improved patient adherence. As a trusted leader in the industry, Optimizerx Corp demonstrates a dedication to excellence, integrity, and creating value for its shareholders, healthcare partners, and the overall community.

Analis saat ini menetapkan target harga rata-rata 10,25 USD untuk saham OptimizeRx (median: 11,00 USD), yaitu +9,7 % terhadap harga terbaru. Konsensus didasarkan pada 12 peringkat analis.

12 analis saat ini menilai saham OptimizeRx: 11 merekomendasikan beli, 1 tahan, dan 0 jual. Untuk 2026, analis memperkirakan OptimizeRx menghasilkan pendapatan 96,23 Juta. USD dan laba per saham 0,86 USD.

Dengan kurs saat ini, saham OptimizeRx diperdagangkan pada 8,37 EUR (9,35 USD).

Saham OptimizeRx (OPRX) tercatat di 1 bursa, termasuk: NASDAQ (OPRX).

The OPTIMIZERx Corp is a leading provider of digital solutions to improve patient communication, adherence, and access to medications. The company is headquartered in Rochester, Michigan and works with numerous pharmaceutical manufacturers, insurers, and pharmacies to optimize healthcare. One of OPTIMIZERx's main products is the Sample Fulfillment System (SFS), a paperless system for ordering and delivering medication samples to doctors. Doctors can access a wide range of medications, order samples, and effectively treat their patients through the system. The SFS is easy to use and provides doctors with a convenient way to receive medications and care for patients. OPTIMIZERx also offers a variety of patient communication solutions to improve compliance and adherence. The OPTIMIZERx portal is an online portal that allows patients to order and manage medications, as well as receive information about their medications and their side effects. The portal is user-friendly and easy to navigate, allowing patients to securely access their medical information. Another important area of OPTIMIZERx is supporting patients with coupons and discounts on prescription medications. OPTIMIZERx offers discount programs for a variety of medications to help patients manage the high costs of their medications. Similarly, OPTIMIZERx offers various options to assist patients in applying for discounts and ensuring they receive the best offer. In addition, OPTIMIZERx also provides communication solutions for pharmacies to improve information exchange and collaboration between pharmacies and doctors. The OPTIMIZERx eCoupon system allows pharmacies to pass on discounts and coupons directly to patients. In summary, the OPTIMIZERx Corp offers a wide range of digital solutions to improve patient communication, increase adherence and compliance, and facilitate access to medications. The company works closely with pharmaceutical manufacturers and other healthcare providers to optimize healthcare and provide the best possible support for patients.

Pendapatan diperkirakan dari OptimizeRx adalah 96,23 Juta. USD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.

Laba diperkirakan dari OptimizeRx adalah 16,71 Juta. USD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.

Rasio harga-terhadap-pendapatan (PER) OptimizeRx saat ini adalah 10,84. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham OptimizeRx.

Rasio harga-terhadap-penjualan (PSR) OptimizeRx saat ini adalah 1,88. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham OptimizeRx.

Skor Kualitas AlleAktien untuk OptimizeRx adalah 5/10.

ISIN dari OptimizeRx adalah US68401U2042. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.

WKN dari OptimizeRx adalah A2JL4Z. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.

Ticker dari OptimizeRx adalah OPRX. Simbol ticker digunakan untuk memperdagangkan saham OptimizeRx di bursa saham.

Nilai WajarTerminal
8,50 USD
Penilaian Berlebihan/KurangTerminal
Dinilai secara wajar
Sektor
Industri
Teknologi Kesehatan
Jumlah Saham
Karyawan
Pendapatan per Karyawan
1,05 Juta. USD
Pertumbuhan Pendapatan Ø5 Tahun
Pertumbuhan EBIT Ø5 Tahun
Pertumbuhan Laba Bersih Ø5 Tahun
Situs Web optimizerx.com
Mata Uang
USD
Penawaran Umum Perdana
18 Mei 2005
ISIN
US68401U2042
CUSIP
68401U204
SEDOL
BF5MM09
Kapitalisasi Pasar
Kisaran 52 Minggu
Rasio PEG
5,82
P/E 2026
10,42
P/E 2027
8,64
P/E 2028
8,73
P/S
P/S
1,88
EV/EBIT
10,39
Rasio P/B
1,36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3,33 %
Terakhir diperbarui 31 Okt 2026, 09.55

OptimizeRx Ticker

NASDAQ · OPRX

OptimizeRx FIGI

OPRX:US · BBG000HKQH91OPRX:UA · BBG000HKQJP9OPRX:UC · BBG000HKQK76OPRX:UN · BBG000HKRND2OPRX:UP · BBG000HKRNQ8OPRX:UB · BBG000HKRPM7OPRX:UM · BBG000HKRSS5OPRX:UX · BBG000HKRT12OPRX:UR · BBG000HKRTM9OPRX:UD · BBG000HKRXW9OPRX:UF · BBG000HKT2S0OPRX:VY · BBG000HKT308

Semua metrik fundamental dan analisis mendalam OptimizeRx

Analisis saham kami untuk saham OptimizeRx mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari OptimizeRx. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.